6Koga H, Shinkai T. Preliminary evaluation of the new tumor markers. CYFRA21-1, in lung cancer patients[J]..lpn J Clin On- col, 1994. 24(5): 263-268.
7]Kawaehi R, Nakazato Y, Takei H, et al. Clinical significance of preoperative eareinoemblTonic antigen LeveL for clinical stage I non-small cell lung cancer: can preoperative careinoembrytmic antigen level predict pathological stage?[J]. Inlevaet Cardio Vase Thorae Sur_,z. 2009. 9t2): 199-202.
8Hiroshi T, Toshiro N, Yoshihiro M. et al. Lung adenocarcinoma with mix*,d bronchinlnalveolar and invasive components: clink:o- pathological features, subclassification by extent of invasive loci. and immunohistochemical characterization [J]. Am J Surg Pathol, 2003, 27(7): 937-951.
9Mitsudomi T, Hamajima N. Ogawa M. et al, Prognostic signifi- caance of p53 aherations in patients with non-small-cell lung cant'er: a meta-analysis[J]. Clin Cancer Res, 2000, 6(10): 4055- 4063.
10Pinson P, Joos G, Watripont P, et al.Serum neuron specific enolase as a tumor maker in the diagnosis and follow up of small cell lung cancer[J] .Respiration, 1997,64( 1 ): 102-107.
